Class information for:
Level 1: CA 15 3//TISSUE POLYPEPTIDE SPECIFIC ANTIGEN//CA 549

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
11659 964 26.6 56%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
6 4 GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY 1371034
608 3       CIRCULATING TUMOR CELLS//CEA//CYFRA 21 1 14209
1581 2             CYFRA 21 1//CEA//CARCINOEMBRYONIC ANTIGEN 7240
11659 1                   CA 15 3//TISSUE POLYPEPTIDE SPECIFIC ANTIGEN//CA 549 964

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CA 15 3 authKW 2677880 17% 51% 165
2 TISSUE POLYPEPTIDE SPECIFIC ANTIGEN authKW 559184 3% 55% 32
3 CA 549 authKW 263948 1% 83% 10
4 TISSUE POLYPEPTIDE ANTIGEN authKW 249890 2% 33% 24
5 TUMOR MARKER authKW 247408 17% 5% 164
6 CEA authKW 193652 8% 8% 80
7 MUCIN LIKE CARCINOMA ASSOCIATED ANTIGEN authKW 190045 1% 100% 6
8 TPS authKW 172657 4% 16% 34
9 TISSUE POLYPEPTIDE SPECIFIC ANTIGEN TPS authKW 172445 1% 78% 7
10 TAG 12 authKW 126697 0% 100% 4

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Oncology 12503 58% 0% 563
2 Medical Laboratory Technology 2361 8% 0% 81
3 Pathology 271 5% 0% 52
4 Obstetrics & Gynecology 104 4% 0% 38
5 Medicine, Research & Experimental 100 5% 0% 48
6 Medicine, General & Internal 79 6% 0% 57
7 Biotechnology & Applied Microbiology 68 5% 0% 49
8 Urology & Nephrology 42 3% 0% 26
9 Radiology, Nuclear Medicine & Medical Imaging 37 4% 0% 36
10 Surgery 20 5% 0% 47

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 REG INDICATORI BIOCHIM TUMORE 35630 0% 38% 3
2 ANATOMIA HUMANA AREA 31674 0% 100% 1
3 ANCILLARY DIAGNOST SERV 31674 0% 100% 1
4 ASSOCIAZ ABO PLICAZ BIOTECNOL ONCOL 31674 0% 100% 1
5 AZIENDA OSPED SANT ANNA 31674 0% 100% 1
6 BP 307 31674 0% 100% 1
7 BREAST ENDOMETRIAL SURG 31674 0% 100% 1
8 CANC OUTPATIENTS 31674 0% 100% 1
9 CANC W TN 31674 0% 100% 1
10 CENT ILLINOIS COMMUNITY 31674 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 JOURNAL OF TUMOR MARKER ONCOLOGY 75831 2% 12% 20
2 TUMORDIAGNOSTIK 65972 1% 21% 10
3 TUMORDIAGNOSTIK & THERAPIE 34227 3% 4% 29
4 JOURNAL OF NUCLEAR MEDICINE AND ALLIED SCIENCES 23889 2% 5% 16
5 ANTICANCER RESEARCH 13395 9% 0% 90
6 INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS 12696 2% 2% 19
7 CANCER DETECTION AND PREVENTION 5100 2% 1% 16
8 JOURNAL OF CLINICAL LIGAND ASSAY 5025 1% 2% 7
9 TUMOR BIOLOGY 4601 3% 0% 30
10 CLINICAL ONCOLOGY-US 3166 0% 10% 1

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 CA 15 3 2677880 17% 51% 165 Search CA+15+3 Search CA+15+3
2 TISSUE POLYPEPTIDE SPECIFIC ANTIGEN 559184 3% 55% 32 Search TISSUE+POLYPEPTIDE+SPECIFIC+ANTIGEN Search TISSUE+POLYPEPTIDE+SPECIFIC+ANTIGEN
3 CA 549 263948 1% 83% 10 Search CA+549 Search CA+549
4 TISSUE POLYPEPTIDE ANTIGEN 249890 2% 33% 24 Search TISSUE+POLYPEPTIDE+ANTIGEN Search TISSUE+POLYPEPTIDE+ANTIGEN
5 TUMOR MARKER 247408 17% 5% 164 Search TUMOR+MARKER Search TUMOR+MARKER
6 CEA 193652 8% 8% 80 Search CEA Search CEA
7 MUCIN LIKE CARCINOMA ASSOCIATED ANTIGEN 190045 1% 100% 6 Search MUCIN+LIKE+CARCINOMA+ASSOCIATED+ANTIGEN Search MUCIN+LIKE+CARCINOMA+ASSOCIATED+ANTIGEN
8 TPS 172657 4% 16% 34 Search TPS Search TPS
9 TISSUE POLYPEPTIDE SPECIFIC ANTIGEN TPS 172445 1% 78% 7 Search TISSUE+POLYPEPTIDE+SPECIFIC+ANTIGEN+TPS Search TISSUE+POLYPEPTIDE+SPECIFIC+ANTIGEN+TPS
10 TAG 12 126697 0% 100% 4 Search TAG+12 Search TAG+12

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 NICOLINI, A , FERRARI, P , ROSSI, G , (2015) MUCINS AND CYTOKERATINS AS SERUM TUMOR MARKERS IN BREAST CANCER.ADVANCES IN CANCER BIOMARKERS: FROM BIOCHEMISTRY TO CLINIC FOR A CRITICAL REVISION. VOL. 867. ISSUE . P. 197 -225 68 53% 0
2 BASUYAU, JP , BLANC-VINCENT, MP , BIDART, JM , DAVER, A , DENEUX, L , ECHE, N , GORY-DELABAERE, G , PICHON, MF , RIEDINGER, JM , (2000) STANDARDS, OPTIONS AND RECOMMENDATIONS (SOR) FOR TUMOR MARKERS IN BREAST CANCER.BULLETIN DU CANCER. VOL. 87. ISSUE 10. P. 723 -737 61 84% 17
3 RIEDINGER, JM , (2010) INTEREST OF TUMOUR MARKERS: WHAT PLACES FOR THE ACE AND THE CA 15-3?.MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE. VOL. 34. ISSUE 1. P. 44-51 39 80% 2
4 STIEBER, P , NAGEL, D , BLANKENBURG, I , HEINEMANN, V , UNTCH, M , BAUERFEIND, I , DI GIOIA, D , (2015) DIAGNOSTIC EFFICACY OF CA 15-3 AND CEA IN THE EARLY DETECTION OF METASTATIC BREAST CANCER-A RETROSPECTIVE ANALYSIS OF KINETICS ON 743 BREAST CANCER PATIENTS.CLINICA CHIMICA ACTA. VOL. 448. ISSUE . P. 228 -231 26 96% 5
5 DUFFY, MJ , (2006) SERUM TUMOR MARKERS IN BREAST CANCER: ARE THEY OF CLINICAL VALUE?.CLINICAL CHEMISTRY. VOL. 52. ISSUE 3. P. 345-351 32 64% 181
6 SOLETORMOS, G , (2001) SEROLOGICAL TUMOR MARKERS FOR MONITORING BREAST CANCER.DANISH MEDICAL BULLETIN. VOL. 48. ISSUE 4. P. 229 -255 70 43% 2
7 CHEUNG, KL , GRAVES, CRL , ROBERTSON, JFR , (2000) TUMOUR MARKER MEASUREMENTS IN THE DIAGNOSIS AND MONITORING OF BREAST CANCER.CANCER TREATMENT REVIEWS. VOL. 26. ISSUE 2. P. 91 -102 43 61% 112
8 MLIKA-CABANNE, N , BELLET, D , (1998) SERUM MARKERS FOR BREAST AND COLORECTAL CANCERS.GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE. VOL. 22. ISSUE 4. P. 442 -457 62 50% 3
9 MOLINA, R , BARAK, V , VAN DALEN, A , DUFFY, MJ , EINARSSON, R , GION, M , GOIKE, H , LAMERZ, R , NAP, M , SOLETORMOS, G , ET AL (2005) TUMOR MARKERS IN BREAST CANCER - EUROPEAN GROUP ON TUMOR MARKERS RECOMMENDATIONS.TUMOR BIOLOGY. VOL. 26. ISSUE 6. P. 281-293 47 42% 157
10 DUFFY, MJ , EVOY, D , MCDERMOTT, EW , (2010) CA 15-3: USES AND LIMITATION AS A BIOMARKER FOR BREAST CANCER.CLINICA CHIMICA ACTA. VOL. 411. ISSUE 23-24. P. 1869 -1874 33 52% 74

Classes with closest relation at Level 1


Rank Class id link
1 9750 CA 19 9//CA 72 4//CA 242
2 9938 CYFRA 21 1//PROGRP//CYTOKERATIN 19 FRAGMENT
3 1584 MUC1//MUC4//MUCIN
4 29102 M65//M30//CYTOKERATIN 18
5 8960 CARCINOEMBRYONIC ANTIGEN//CEA//SYNCHRONOUS COLORECTAL CANCER
6 2789 CA 125//HE4//CA125
7 9080 SURVIVORSHIP CARE PLAN//TREATMENT SUMMARIES//FOLLOW UP CARE
8 7780 CEACAM1//BILIARY GLYCOPROTEIN//CEACAM6
9 24054 PLACENTAL ISOFERRITIN//P43 ISOFERRITIN//PLACENTAL FERRITIN
10 19922 SQUAMOUS CELL CARCINOMA ANTIGEN//SCC ANTIGEN//SERPINB3

Go to start page